Home › Two experimental Ebola vaccines pass safety test in African trial
 

Keywords :   


Two experimental Ebola vaccines pass safety test in African trial

2015-03-27 00:17:51| Biotech - Topix.net

Two experimental Ebola vaccines, one from GlaxoSmithKline PLC and the other from biotech start-up NewLink Genetics Corp, "appear to be safe" part way through a clinical trial being conducted in Liberia, the U.S. National Institutes of Health said on Thursday. The two vaccines, each given in a single injection, are being tested for safety and efficacy on more than 600 people in Liberia in a mid-stage clinical trial sponsored by the National Institute of Allergy and Infectious Diseases, a branch of NIH.

Tags: test safety pass trial

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.05Exploring the future of agriculture
15.05American, Mexican, and Canadian cattle producers sign joint statement
15.05Attitudes EWG Verified Skincare Line Oceanly Expands with SPF Offerings
15.05Sherwin-Williams Packaging Coatings Expands Non-BPA Coatings Production in Europe
15.05Voesh Unveils Body Refining Roller Crme Ahead of Summer 2024
15.05KANSAI HELIOS Completes Acquisition of WEILBURGER Coatings
15.05TSCRA Disaster Relief Fund distributes $900,000 in financial assistance
15.05Portugal\'s Etifam adds Screen Truepress Label 350UV SAI-E
More »